Fabry Disease
- Name
- Fabry Disease
- Accession Number
- DBCAT000217
- Description
Not Available
- Drugs
Drug Drug Description Pegunigalsidase alfa A recombinant form of human α-galactosidase-A indicated for long-term enzyme replacement therapy in patients with Fabry disease. - Drugs & Drug Targets
Drug Target Type Pegunigalsidase alfa Globotriaosylceramide target